SHSE:688513's Forward Dividend Yield % is ranked worse than 64.63% of 147
companies
in the Biotechnology industry
Industry Median: 1.3
vs SHSE:688513: 0.83
During the past 12 months, Chengdu Easton Biopharmaceuticals Co's average Dividends Per Share Growth Rate was -25.90% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -6.80% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Chengdu Easton Biopharmaceuticals Co was 41.70% per year. The lowest was -6.80% per year. And the median was 17.45% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Chengdu Easton Biopharmaceuticals Co Forward Dividend Yield % Related Terms
SHSE:688513 vs VRTX, REGN, ALNY: Forward Dividend Yield % Comparison
For the Biotechnology subindustry, Chengdu Easton Biopharmaceuticals Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chengdu Easton Biopharmaceuticals Co Forward Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Chengdu Easton Biopharmaceuticals Co's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Chengdu Easton Biopharmaceuticals Co's Forward Dividend Yield % falls into.
Chengdu Easton Biopharmaceuticals Co Forward Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Chengdu Easton Biopharmaceuticals Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CNY 0.490000
2026-06-02
2026-06-01
2026-06-02
Cash Dividend
annually
CNY:CNY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 0.83% mean?
Chengdu Easton Biopharmaceuticals Co (SHSE:688513) has a Forward Dividend Yield % of 0.83% as of Jul. 07, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Chengdu Easton Biopharmaceuticals Co and its competitors. According to the industry distribution chart, Chengdu Easton Biopharmaceuticals Co ranks #95 out of 147 companies in the Biotechnology industry, placing it in the top 64.6%.
Is Chengdu Easton Biopharmaceuticals Co's Forward Dividend Yield % too high?
Chengdu Easton Biopharmaceuticals Co's current Forward Dividend Yield % is 0.83%. The Biotechnology industry median Forward Dividend Yield % is 1.30. Chengdu Easton Biopharmaceuticals Co's value of 0.83% is 36.2% below this industry median. Based on the distribution chart, Chengdu Easton Biopharmaceuticals Co ranks #95 out of 147 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Chengdu Easton Biopharmaceuticals Co has a GF Score™ of 95/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chengdu Easton Biopharmaceuticals Co's Forward Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Chengdu Easton Biopharmaceuticals Co ranks #95 out of 147 companies for Forward Dividend Yield %. This places Chengdu Easton Biopharmaceuticals Co in the lower half of its industry. The industry median Forward Dividend Yield % is 1.30. Chengdu Easton Biopharmaceuticals Co's value of 0.83% is 36.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.30, based on 147 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chengdu Easton Biopharmaceuticals Co's current Forward Dividend Yield % of 0.83% is 36.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Chengdu Easton Biopharmaceuticals Co and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chengdu Easton Biopharmaceuticals Co's current Forward Dividend Yield % is 0.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chengdu Easton Biopharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Chengdu Easton Biopharmaceuticals Co (SHSE:688513) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥47.90, compared to a current price of ¥55.10 — trading 15% above its estimated fair value. The current Forward Dividend Yield % is 0.83% and 36.2% below the Biotechnology industry median of 1.30. Chengdu Easton Biopharmaceuticals Co's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Chengdu Easton Biopharmaceuticals Co (SHSE:688513), the current Forward Dividend Yield % is 0.83% as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Overvalued in 2026?
Based on GuruFocus' analysis, Chengdu Easton Biopharmaceuticals Co stock appears to be overvalued.
The current stock price of ¥55.10 is trading 15% above its estimated GF Value™ of ¥47.90.
GuruFocus considers Chengdu Easton Biopharmaceuticals Co to be Modestly Overvalued.
Key valuation signals for SHSE:688513:
Forward Dividend Yield %: 0.83%
GF Value™: ¥47.90 vs. price of ¥55.10 (15% above fair value)
Industry Position: 36.2% below the Biotechnology median (#95 of 147)
No single metric tells the full story. See the SHSE:688513 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chengdu Easton Biopharmaceuticals Co Business Description
Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.
95GF Score
Get the complete analysis for SHSE:688513
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688513 has been successfully added to your 